Rekombinanter N-Cadherin Antikörper (full length)
Kurzübersicht für Rekombinanter N-Cadherin Antikörper (full length) (ABIN7877738)
Target
Alle N-Cadherin (CDH2) Antikörper anzeigenAntikörpertyp
Reaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
-
-
Bindungsspezifität
- full length
-
Verwendungszweck
- Recombinant Cadherin 2 Antibody / CDH2 / N-Cadherin
-
Aufreinigung
- Protein A/G affinity
-
Immunogen
- Recombinant full-length human protein was used as the immunogen for the recombinant Cadherin 2 antibody.
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- Optimal dilution of the recombinant Cadherin 2 antibody should be determined by the researcher.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 0.2 mg/mL
-
Buffer
- 0.2 mg/mL in 1X PBS with 0.1 mg/mL BSA (US sourced), 0.05 % sodium azide
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Aliquot the recombinant Cadherin 2 antibody and store frozen at -20oC or colder. Avoid repeated freeze-thaw cycles.
-
-
- N-Cadherin (CDH2) (Cadherin 2 (CDH2))
-
Andere Bezeichnung
- Cadherin 2
-
Hintergrund
- Recognizes a protein of ~140 kDa, identified as N-Cadherin (NCAD), also known as CD325, Cadherin 2 and CDH2. CDH2 is a member of the Cadherin superfamily, and consists of five extracellular repeats, a transmembrane domain and a cytoplasmic domain. CDH2 deficient mice die at day 10 of gestation and embryos display major heart defects and malformed neural tubes and somites. Consistent with this, the protein has been implicated in several aspects of cardiac development including the precardiac mesoderm, establishment of left-right symmetry and cardiac looping morphogenesis. Furthermore, CDH2 is normally involved in inducing cell cycle arrest and its expression is frequently deregulated in cancer cells. Studies have linked N-cadherin to cancer metastasis by showing the aggressive tumor cells had preferentially turned on N-cadherin as opposed to E- or P-cadherin.
-
UniProt
- P19022
-
Pathways
- Regulation of Muscle Cell Differentiation, Cell-Cell Junction Organization, Synaptic Membrane
Target
-